Regenerative repair of elastic matrix in the AAA wall is naturally poor due to intrinsically poor elastogenicity of adult and diseased vascular SMCs 4]. In this scenario, cell therapy involving delivery of an alternate, possibly autologous cell type that would exhibit the high contractility of terminally differentiated SMCs in healthy vessels and yet exhibit the high elastogenic potential of SMC progenitor cells in early development would proffer...